King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

0
Player Avatar Dragontoad2 (91.53) Submitted: 7/2/2008 9:14:19 AM : Outperform Start Price: $10.50 KG Score: +29.90

price/book =1.. solid numbers

Report this Post Reply

Featured Broker Partners


Advertisement